Lyrica (pregabalin) Letter of Medical Necessity
Lyrica (pregabalin) PA denials are usually correctable with documentation of indication, prior gabapentin trial, and severity of symptoms.
FDA-Approved Indications
- ● neuropathic pain (DPN, PHN, spinal cord injury)
- ● partial-onset seizures
- ● fibromyalgia
Why Lyrica Prior Authorization Gets Denied
The most common denial reasons across major payers:
- 1. Generic pregabalin preferred
- 2. Gabapentin trial not documented
- 3. Indication not specified
What to Include in a Lyrica Letter of Medical Necessity
Document diagnosis, pain or seizure severity scoring, prior antiepileptic/analgesic trials, and clinical rationale for pregabalin selection.
Key clinical evidence to cite:
- ✓ Multiple pivotal trials per indication
Relevant guidelines:
- 📖 AAN Diabetic Neuropathy Guidelines
- 📖 CDC Pain Management Guidelines
Lyrica Prior Authorization Criteria
Standard criteria across major US payers for Lyrica. Specific criteria vary by plan — RxCheckUp tailors each LMN to your patient's exact payer policy.
Typical step therapy requirements:
- → Gabapentin trial not documented
Required documentation:
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy history with dates, doses, and discontinuation reasons
- ✓ Specialist evaluation (where applicable)
- ✓ Baseline disease activity or biomarker results
- ✓ Clinical rationale citing FDA labeling or guidelines
Approval details:
Initial approval: typically 6 months. Renewal: 12 months with documented clinical response.
Payers Covering Lyrica
RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:
Lyrica Prior Authorization FAQ
Why was my Lyrica prior authorization denied?
The most common denial reasons for Lyrica are: Generic pregabalin preferred; Gabapentin trial not documented; Indication not specified.
What should a Lyrica Letter of Medical Necessity include?
Document diagnosis, pain or seizure severity scoring, prior antiepileptic/analgesic trials, and clinical rationale for pregabalin selection.
Which payers cover Lyrica?
Lyrica is covered by major US payers including Medicare Part D, UnitedHealthcare, Aetna, Cigna, BCBS, though formulary tier and prior authorization criteria vary.